Kim M H, Hahn T H
Department of Anesthesiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Anesth Analg. 2000 Jun;90(6):1441-4. doi: 10.1097/00000539-200006000-00035.
We investigated the hypothesis that oral clonidine premedication would decrease the release of proinflammatory cytokines interleukin (IL)-6, IL-1beta, and tumor necrosis factor-alpha, and stress hormones cortisol and adrenocorticotropic hormone (ACTH), in patients who underwent total abdominal hysterectomy. Twenty patients were randomly assigned to one of two groups: the control group received no premedication, whereas the treatment group received clonidine 0.15 mg oral dose 90 min before surgery. Venous blood samples were obtained at preinduction time and immediately, 1, and 3 h after the start of surgery. IL-6 increased significantly at 3 h, and cortisol and ACTH at 1 and 3 h after the start of surgery compared with the baseline values within both groups. IL-1beta levels decreased at all times compared with the baseline value in the control group. In the comparison study between the control group and the clonidine group, there was a significant decrease in IL-6 level 3 h after the start of surgery and IL-1beta at preinduction time in the clonidine group, whereas there were no changes in tumor necrosis factor-alpha, cortisol, and ACTH levels. These results show that clonidine modulates the IL-6 response related to surgical stress.
We assessed the effect of the alpha(2)-adrenoreceptor agonist clonidine on the immunoendocrine activity during the perioperative period. Clonidine 0.15 mg given as oral premedication resulted in the reduced Interleukin-6 production in response to total abdominal hysterectomy.
我们研究了这样一个假设,即在接受全腹子宫切除术的患者中,口服可乐定进行术前用药会减少促炎细胞因子白细胞介素(IL)-6、IL-1β和肿瘤坏死因子-α以及应激激素皮质醇和促肾上腺皮质激素(ACTH)的释放。20名患者被随机分为两组之一:对照组未进行术前用药,而治疗组在手术前90分钟口服0.15毫克可乐定。在诱导前以及手术开始后即刻、1小时和3小时采集静脉血样本。与两组内的基线值相比,手术开始后3小时IL-6显著升高,手术开始后1小时和3小时皮质醇和ACTH升高。与对照组的基线值相比,IL-1β水平在所有时间均降低。在对照组和可乐定组的比较研究中,手术开始后3小时可乐定组的IL-6水平以及诱导前的IL-1β显著降低,而肿瘤坏死因子-α、皮质醇和ACTH水平没有变化。这些结果表明可乐定可调节与手术应激相关的IL-6反应。
我们评估了α₂肾上腺素能受体激动剂可乐定在围手术期对免疫内分泌活性的影响。口服0.15毫克可乐定进行术前用药可减少全腹子宫切除术后白细胞介素-6的产生。